IncredibleBuzz Introduces 'SuneKos' at IMCAS 2025... "Industry Attention Focused"

Incredible Buzz, a company specializing in beauty and slow aging, announced on the 7th that it participated in the 2025 IMCAS (International Master Course on Aging Science) World Congress and received great attention from participants by introducing the bio stimulator 'suneKOS'.

The 'IMCAS World Congress 2025,' held in Paris, France from January 30 to February 1, is the world's largest beauty and plastic surgery conference, with about 18,700 attendees from 136 countries sharing innovative research results on the latest beauty medicine and aging science.

At this event, Incredible Buzz's 'suneKOS' booth was continuously visited by attendees. Experts and industry insiders showed great interest in suneKOS's outstanding technology in the rapidly emerging bio stimulator market.

suneKOS is an injectable product based on an amino acid formula independently developed by the Italian company Professional Dietetics. It is made by combining six amino acids and hyaluronic acid (HY6AA). Unlike existing bio stimulator products such as poly-L-lactic acid (PLLA) and poly-D,L-lactic acid (PDLLA), it has the advantage of no fibrotic side effects and reduced inflammatory responses.

Moreover, while existing products generate type 3 collagen due to inflammatory responses, suneKOS promotes the self-generation of type 4 and 7 collagen and fibronectin. It also activates elastin production, enhancing skin elasticity and improving aging.

The company also independently conducted a workshop for medical professionals before the official IMCAS event. Dr. Marko Mance, M.D., Ph.D., an expert in plastic, reconstructive, and cosmetic surgery, and Dr. Abs served as instructors, educating domestic and international doctors on the mechanism and procedure of suneKOS. Doctors attending the workshop highly praised suneKOS's product quality and safety.

Im Shin-young, CEO of Incredible Buzz, who led 'Motiva Korea' to become the number one market share holder in the domestic breast implant market, expressed great expectations for the success of suneKOS. CEO Im stated, “suneKOS was evaluated as the next-generation bio stimulator at IMCAS, surpassing existing leading products in the market. Going forward, suneKOS will occupy a leading position in the bio stimulator market with its excellent technology.”